The biomedical data landscape is fragmented with several isolated, heterogeneous data
and knowledge sources, which use varying formats, syntaxes, schemas, and entity …

Background Current approaches to identifying drug-drug interactions (DDIs), include safety
studies during drug development and post-marketing surveillance after approval, offer …

Background Drug product data is available on the Web in a distributed fashion. The reasons
lie within the regulatory domains, which exist on a national level. As a consequence, the …

Integrated approaches for pharmacology are required for the mechanism-based predictions
of adverse drug reactions that manifest due to concomitant intake of multiple drugs. These …

Background Pathogenesis of inflammatory diseases can be tracked by studying the
causality relationships among the factors contributing to its development. We could, for …

We investigate the current extent of term reuse and overlap among biomedical ontologies.
We use the corpus of biomedical ontologies stored in the BioPortal repository, and analyze …

Taxonomies and its related technologies ontologies, schemas, directories, and electronic
catalogs are using a hierarchical order to model a field of interest in a formal way and have …

Adverse drug reactions (ADR) result in significant morbidity and mortality in patients, and a
substantial proportion of these ADRs are caused by drug–drug interactions (DDIs) …

PanglaoDB is a database of cell-type markers widely used for single-cell RNA sequencing
data analysis. However, cell types and genes in the database are encoded by free text …

DNA sequencing technology has revolutionized the field of biology, shifting biology from a
data-limited to data-rich state. Central to the interpretation of sequencing data are the …